Skip to Content

335 (Pyridostigmine Bromide Extended-Release 180 mg)

Pill with imprint 335 is Yellow, Capsule-shape and has been identified as Pyridostigmine Bromide Extended-Release 180 mg. It is supplied by Alvogen, Inc..

Pyridostigmine is used in the treatment of myasthenia gravis; nerve agent pretreatment; reversal of nondepolarizing muscle relaxants and belongs to the drug class cholinergic muscle stimulants. Risk cannot be ruled out during pregnancy. Pyridostigmine 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 335

Pyridostigmine bromide extended-release 180 mg 335

Pyridostigmine Bromide Extended-Release

Imprint
335
Strength
180 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinergic muscle stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alvogen, Inc.
National Drug Code (NDC)
47781-0335

Get help with Imprint Code FAQs.

Related Images for "335"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.